Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | An insight into the aims, resources and ongoing projects of the LLS

Gwen Nichols • 12 Dec 2022
ASH 2022
General

In this video, Gwen Nichols, MD, Leukemia & Lymphoma Society, New York, NY, shares some insights into ongoing activities and resources at the Leukemia & Lymphoma Society (LLS), including patient advocacy, educational resources, and information on clinical trials. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Gwen Nichols

The PedAL master trial and sub-studies: accelerating drug development in pediatric acute leukemias
4:52
The PedAL master trial and sub-studies: accelerating drug development in pediatric acute leukemias
Gwen Nichols • 6 Dec 2025
The challenges with pediatric trials in oncology
2:32
The challenges with pediatric trials in oncology
Gwen Nichols • 16 May 2025
Investigating venetoclax in children with R/R AML: a sub-trial of the PedAL master trial
3:52
Investigating venetoclax in children with R/R AML: a sub-trial of the PedAL master trial
Gwen Nichols • 16 May 2025
Investigating a menin inhibitor in pediatric acute leukemia: a sub-trial of the PedAL trial
3:25
Investigating a menin inhibitor in pediatric acute leukemia: a sub-trial of the PedAL trial
Gwen Nichols • 16 May 2025

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals